Cymbalta® (duloxetine HCl) is a drug manufactured by Eli Lilly Company that is sometimes prescribed for the treatment of depression and generalized anxiety disorder, for the management of diabetic peripheral neuropathic pain and fibromyalgia.
Accumulating medical reports confirm that patients can have significant side effects if they try to stop taking Cymbalta. Our investigation is focused on side effects of Cymbalta, including withdrawal symptoms when coming off Cymbalta.
Even Eli Lilly, the maker of Cymbalta, acknowledges that patients who are trying to discontinue use of Cymbalta can encounter symptoms like dizziness, nausea, headache, fatigue, paresthesia, vomiting, irritability, nightmares, insomnia, diarrhea, anxiety, hyperhydrosis and vertigo.
But Eli Lilly fails to adequately describe the frequency and severity of side effects when trying to discontinue use of Cymbalta or acknowledge that withdrawal side effects can occur even with a gradual reduction in the dose that Eli Lilly recommends. The accumulating evidence from medical studies shows that the side effects of stopping Cymbalta are significant, disturbingly frequent, and can be present with both gradual and abrupt discontinuation.
Our firms are investigating problems with symptoms from the discontinuation of use of Cymbalta. Please use the form below to tell us about your situation. We will contact you by phone as soon as possible.
WE USE YOUR ANSWERS ON THIS FORM TO DETERMINE WHETHER YOU MAY BE PART OF OUR CYMBALTA LITIGATION. PLEASE FILL OUT THE WHOLE FORM AND GIVE THE CORRECT ANSWERS TO OUR QUESTIONS. YOU WILL HEAR FROM US WITHIN 5 BUSINESS DAYS OF FILLING OUT THIS FORM.
Your confidentiality matters. No information, including phone numbers and email addresses will be exchanged, shared or sold to a third party. Any communications to our firm via contact forms, email, phone or U.S. mail, will be treated confidentially. Submissions are made for the purpose of evaluating whether or not our law firm will accept your case and represent you. However, all information contained in your submission will be held confidential. By evaluating your submission we make no representation or agreement to represent you in connection with your claim. Thank you.